Investing News NetworkDecember 19, 2024Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trialDownload the PDF here.
Investing News Network29 August 2025 Appendix 4E and Preliminary Final Report Radiopharm Theranostics (RAD:AU) has announced Appendix 4E and Preliminary Final ReportDownload the PDF here. Keep Reading...
Investing News Network29 July 2025 Quarterly Activities/Appendix 4C Cash Flow Report Radiopharm Theranostics (RAD:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
Investing News Network27 July 2025 RAD receives IND approval from US FDA for Betabart (RV-01) Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)Download the PDF here. Keep Reading...
Investing News Network10 June 2025 RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases ImagingDownload the PDF here. Keep Reading...
Investing News Network03 June 2025 RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202Download the PDF here. Keep Reading...
Cygnus intends to advance resource evaluation and technical studies following successful A$25m placement 7h
gold investing Summit Royalties: Rapidly Scaling a Diversified Precious Metals Royalty and Streaming Portfolio 1h
base metals investing Cygnus intends to advance resource evaluation and technical studies following successful A$25m placement 7h
oil and gas investing Top 5 Australian Mining Stocks This Week: Oil Company 88 Energy Soars 73 Percent 10h
lithium investing LFP Batteries Claim 60 Percent of Global Market as North America Scrambles to Build Supply Chain 10h